Winners UK MDS FORUMS Grants 2019
15th International Symposium on Myelodysplastic Syndromes 8 - 11 May Copenhagen, Denmark
The UK MDS Forum is pleased to announce that there will be two grants available for doctors and four for nurses for attendance at this meeting. Each grant will be for £1500.
The committee is pleased to announce the winners for 2019
Copenhagen: Kiran Batta, John Chadwick, Jessica Timms, Anjum Khan, Hana Mohamed Amsterdam (EHA): Lesley Candlin
Winner The MDS UK Patients Group Research Grant 2019
MDS UK Patient Support Group will fully fund a PhD student for up to four years in a UK academic institution. Funding will include fees, Stipend at UKRI level including inflation at 4%, consumables and appropriate travel costs for scientific meetings. Please note that the Grant will not fund the clinical salaries of medical staff.
UK MDS FORUMS Grants 2017
14th International Symposium on Myelodysplastic Syndromes - 3-6 May 2017
Grants available for the upcoming 14th International Symposium on MDS – May 3-6 2017.
The committee is pleased to announce the winners for 2017.
Matthew Cullen and Anna Gibson each grant will be for € 2000.
The winner of the EHA award 2015
Winning Scientist - Simona Valletta, LLR Molecular Haematology Unit, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, John Radcliffe Hospital, Oxford, UK
Abstract title:Correction Of Mutations Of The Epigenetic Modifier ASXL1 In Myeloid Leukemia Cells By CRISPR/Cas9 Genome Editing.
The two winners of the EHA award 2014
Winning clinician - Elena Crisa, Honorary Clinical Research Fellow, Department of Haematology Research, King's College Hospital NHS Foundation Trust, London/Abstract title: Isolated total monosomy 7 is associated with better prognosis in a large cohort of MDS patients compared with other abnormalities of chromosome 7 - a single institute experience.
Winning Scientist - Andrea Pellagatti, LLR Molecular Haematology Unit, Nuffield Division of Clinical Lab Sciences, University of Oxford/Abstract title: Comprehensive analysis of mutation status, gene expression profiles, blood and bone marrow counts and outcome in patients with myelodysplastic syndromes.